This Week in Biotech: Dynavax Technologies Corporation (DVAX), Zogenix, Inc. (ZGNX)
With the SPDR S&P Biotech Index up 23% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Dynavax Technologies Corp (DVAX)
Market is closed
News
- First
- << Previous
- 71 - 76
3 Horrendous Health-Care Stocks This Week: VIVUS, Inc. (VVUS), Accretive Health, Inc. (AH), Dynavax Technologies Corporation (DVAX)
While the federal government now gets to deal with "massive" budget cuts of around 2.3% of total annual federal spending put into law by President Obama and Congress, some investors are left wishing they...
What's Next for Dynavax Technologies Corporation (DVAX)?
Dynavax Technologies Corporation (NASDAQ:DVAX) is down more than 30% in early trading today following a Food and Drug Administration rejection for its hepatitis B vaccine Heplisav.
Buy, Sell, or Hold: Vical Incorporated (VICL)
When considering any stock for your portfolio, don't be swayed by just the positives. Examine its pros and cons, and decide whether it's possible that the upside outweighs its risks.
5 Can't-Miss Health-Care Events This Week: Dynavax Technologies Corporation (DVAX) and More
Earnings are once again going to steal the spotlight this week, with four of the five can't-miss stories in the health-care sector revolving around earnings reports.
Wall Street Loves Dynavax Technologies Corporation (DVAX). Should You?
Despite all of Wall Street's conflict and contention, a fortunate few companies enjoy unanimous support among professional analysts.
- First
- << Previous
- 71 - 76
Billionaire Hedge Funds
